A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine
Authors:
Posted in Papers / Human Studies|Original Research / August 1-15, 2025
Cephalalgia. 2025 Jul;45(7):3331024251355947. doi: 10.1177/03331024251355947. Epub 2025 Jul 30.
PMID: 40734466 | DOI: 10.1177/03331024251355947
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.